logo
Select company
Select metric
$ -40.77MConsolidated Income
VS
Market
22
Sector
43
Industry
30
History
41
$ 1.53Close
$ 0.89 - $ 3.14 52-Week Range
Ticker Information

Ticker

TELA

Company Name

TELA BIO INC

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

TELA BIO INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TELA - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -40.77M
3/31/2025$ -43.44M
12/31/2024$ -37.84M
9/30/2024$ -41.52M
6/30/2024$ -42.11M
3/31/2024$ -40.3M
12/31/2023$ -46.66M
9/30/2023$ -43.75M
6/30/2023$ -43.51M
3/31/2023$ -45.46M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TELA BIO INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -27.54M.
  • Over the past 5 years, TELA BIO INC's average Cons. Inc. has been $ -38.64M.
  • The median Cons. Inc. for TELA BIO INC during this period was $ -40.63M
  • TELA BIO INC reached its highest Cons. Inc. over the past 5 years at $ -27.54M.
  • The lowest Cons. Inc. recorded by TELA BIO INC in the same timeframe $ -46.66M

TELA BIO INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
LUNG : PULMONX CORP $ -56.94MAPYX : APYX MEDICAL CORP $ -17.29MRCEL : AVITA MEDICAL INC $ -51.57MMYO : MYOMO INC $ -9.32MBDSX : BIODESIX INC $ -41.08MSRTS : SENSUS HEALTHCARE INC $ -848KCTSO : CYTOSORBENTS CORP $ -9.75MANIK : ANIKA THERAPEUTICS INC $ -60.63MMDAI : SPECTRAL AI INC $ -14.32MXTNT : XTANT MEDICAL HOLDINGS INC $ -4.58M

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

TELA - Consolidated Income, Last 5 years

$ -46.66M

Minimum

Dec 31, 2023

$ -27.54M

Maximum

Sep 30, 2020

$ -38.64M

Average

$ -40.63M

Median

Cons. Inc. Benchmark Analysis

The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.05M with a standard deviation of $ 116.48M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.05M
median$ -2.09M
std$ 116.48M